Sweden

Neuroscience Parkinson's disease
#Neurology #Norway #Parkinson's #Sweden

Parkinson’s could be identified in the blood, study shows 

Early signs of Parkinson’s disease can be identified in the blood, new research suggests.  In a new study published in npj Parkinson’s Disease, a research team from Chalmers University of Technology, Sweden and Oslo University Hospital, Norway identified biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage has occurred. Read More

#News

Theranostic radiopharmaceuticals
#Affibody #Radiopharmaceuticals #Sweden

Affibody secures SEK 307m with fully guaranteed rights issue 

Swedish radiopharmaceuticals company Affibody Medical has secured SEK 307 million ($34 million) by carrying out a fully guaranteed rights issue.  Affibody’s main shareholder Patricia Industries, part of Investor AB, has via its subsidiary Duba AB committed to subscribe for its pro rata share, as well as any remaining shares not subscribed… Read More

#Business & Investment #News

#Akiram Therapeutics #Clinical trials #Radiotherapy #Sweden

First patient enrolled in Phase I trial of Akiram’s cancer drug

Akiram Therapeutics, a Swedish biotech company specialising in targeted radiotherapy, has enrolled the first patient in the Phase I clinical trial of its drug candidate 177Lu-AKIR001. The trial is being conducted at Karolinska University Hospital, which also acts as the study sponsor, and marks an important milestone in Akiram’s efforts… Read More

#Cancer Research #News

Drug discovery innovation
#AAV #Cell and gene therapy #Drug development #Drug discovery #Gene therapy #Genetics / genomics #Immunology / Virology & Vaccines #Interview #Life sciences #Market reporting #Precision medicine #RNA #RNA sequencing #Scandinavia #Sweden #Transcriptomics

Podcast: Innovation drivers and opportunities for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Optimising AAV capsid purification through improved analytics How… Read More

#News

Scandinavia
#Drug development #Drug discovery #Life sciences #Market reporting #Scandinavia #Sweden

Scandinavia: insight into opportunities for drug discovery

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia… Read More

#Exclusive Content #Market Reports